Watanabe O - Search Results

1

Epirubicin and cyclophosphamide followed by docetaxel as primary systemic chemotherapy in locally advanced breast cancer.

Hirano A, Shimizu T, Watanabe O, Kinoshita J, Kimura K, Kamimura M, Domoto K, Aiba M, Ogawa K. Hirano A, et al. Among authors: watanabe o. Anticancer Res. 2008 Nov-Dec;28(6B):4137-42. Anticancer Res. 2008. PMID: 19192673 Free article. Clinical Trial.

2

Monotherapy with paclitaxel as third-line chemotherapy against anthracycline-pretreated and docetaxel-refractory metastatic breast cancer.

Kinoshita J, Haga S, Shimizu T, Imamura H, Watanabe O, Nagumo H, Utada Y, Okabe T, Kimura K, Hirano A, Kajiwara T. Kinoshita J, et al. Among authors: watanabe o. Breast Cancer. 2002;9(2):166-9. doi: 10.1007/BF02967582. Breast Cancer. 2002. PMID: 12016397

3

Experience of intravenous digital subtraction angiography (IV-DSA) in evaluation of neoadjuvant chemotherapy for advanced breast cancer.

Watanabe O, Haga S, Shimizu T, Imamura H, Kinoshita J, Utada Y, Okabe T, Kimura K, Hirano A, Kajiwara T, Aiba M. Watanabe O, et al. Int J Clin Oncol. 2002 Oct;7(5):322-5. doi: 10.1007/s101470200048. Int J Clin Oncol. 2002. PMID: 12402068

4

Expression of cyclooxygenase-2 in malignant and benign breast tumors.

Watanabe O, Shimizu T, Imamura H, Kinoshita J, Utada Y, Okabe T, Kimura K, Hirano A, Yoshimatsu K, Aiba M, Ogawa K. Watanabe O, et al. Anticancer Res. 2003 Jul-Aug;23(4):3215-21. Anticancer Res. 2003. PMID: 12926055

5

[Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].

Watanabe O, Shimizu T, Imamura H, Kinoshita J, Okabe T, Ogawa K, Haga S. Watanabe O, et al. Gan To Kagaku Ryoho. 2004 May;31(5):717-21. Gan To Kagaku Ryoho. 2004. PMID: 15170979 Clinical Trial. Japanese.

6

Expression of twist and wnt in human breast cancer.

Watanabe O, Imamura H, Shimizu T, Kinoshita J, Okabe T, Hirano A, Yoshimatsu K, Konno S, Aiba M, Ogawa K. Watanabe O, et al. Anticancer Res. 2004 Nov-Dec;24(6):3851-6. Anticancer Res. 2004. PMID: 15736421 Free article.

7

The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer.

Hirano A, Shimizu T, Imamura H, Watanabe O, Kinoshita J, Okabe T, Kimura K, Kamimura M, Domoto K, Aiba M, Ogawa K. Hirano A, et al. Among authors: watanabe o. Anticancer Res. 2006 Jan-Feb;26(1B):581-4. Anticancer Res. 2006. PMID: 16739324 Free article. Clinical Trial.

8

Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.

Shimizu T, Hirano A, Watanabe O, Kinoshita J, Kimura K, Kamimura M, Domoto K, Kim N, Ogawa K, Fujibayashi M. Shimizu T, et al. Among authors: watanabe o. Anticancer Res. 2010 Feb;30(2):581-5. Anticancer Res. 2010. PMID: 20332474

9

A phase II study of epirubicin and cyclophosphamide followed by weekly paclitaxel with or without trastuzumab as primary systemic therapy in locally advanced breast cancer.

Shimizu T, Hirano A, Kamimura M, Ogura K, Kim N, Watanabe O, Kinoshita J, Kimura K, Ogawa K, Fujibayashi M. Shimizu T, et al. Among authors: watanabe o. Anticancer Res. 2010 Nov;30(11):4665-71. Anticancer Res. 2010. PMID: 21115921 Clinical Trial.

10

Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice.

Haga S, Shimizu T, Imamura H, Watanabe O, Kinoshita J, Fukushima M, Kajiwara T. Haga S, et al. Among authors: watanabe o. Anticancer Res. 1999 May-Jun;19(3A):1791-6. Anticancer Res. 1999. PMID: 10470117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters